Estabrook Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,359
| Closed | -$146K | – | 446 |
|
|
2021
Q3 | $146K | Hold |
3,359
| – | – | 0.02% | 144 |
|
|
2021
Q2 | $144K | Hold |
3,359
| – | – | 0.02% | 148 |
|
|
2021
Q1 | $130K | Hold |
3,359
| – | – | 0.02% | 154 |
|
|
2020
Q4 | $121K | Hold |
3,359
| – | – | 0.02% | 154 |
|
|
2020
Q3 | $128K | Hold |
3,359
| – | – | 0.02% | 143 |
|
|
2020
Q2 | $118K | Hold |
3,359
| – | – | 0.02% | 146 |
|
|
2020
Q1 | $110K | Hold |
3,359
| – | – | 0.02% | 141 |
|
|
2019
Q4 | $152K | Hold |
3,359
| – | – | 0.02% | 152 |
|
|
2019
Q3 | $137K | Hold |
3,359
| – | – | 0.02% | 152 |
|
|
2019
Q2 | $144K | Hold |
3,359
| – | – | 0.02% | 149 |
|
|
2019
Q1 | $129K | Hold |
3,359
| – | – | 0.02% | 150 |
|
|
2018
Q4 | $119K | Hold |
3,359
| – | – | 0.02% | 147 |
|
|
2018
Q3 | $129K | Hold |
3,359
| – | – | 0.02% | 154 |
|
|
2018
Q2 | $110K | Sell |
3,359
-1,200
| -26% | -$36.2K | 0.02% | 158 |
|
|
2018
Q1 | $125K | Hold |
4,559
| – | – | 0.02% | 160 |
|
|
2017
Q4 | $113K | Hold |
4,559
| – | – | 0.02% | 165 |
|
|
2017
Q3 | $133K | Hold |
4,559
| – | – | 0.02% | 165 |
|
|
2017
Q2 | $126K | Hold |
4,559
| – | – | 0.02% | 166 |
|
|
2017
Q1 | $113K | Hold |
4,559
| – | – | 0.02% | 171 |
|
|
2016
Q4 | $98.6K | Hold |
4,559
| – | – | 0.02% | 182 |
|
|
2016
Q3 | $109K | Hold |
4,559
| – | – | 0.02% | 172 |
|
|
2016
Q2 | $107K | Hold |
4,559
| – | – | 0.02% | 168 |
|
|
2016
Q1 | $85.8K | Hold |
4,559
| – | – | 0.01% | 189 |
|
|
2015
Q4 | $84.1K | Hold |
4,559
| – | – | 0.01% | 194 |
|
|
2015
Q3 | $74.8K | Hold |
4,559
| – | – | 0.01% | 201 |
|
|
2015
Q2 | $80.7K | Hold |
4,559
| – | – | 0.01% | 209 |
|
|
2015
Q1 | $80.9K | Hold |
4,559
| – | – | 0.01% | 224 |
|
|
2014
Q4 | $60.4K | Hold |
4,559
| – | – | 0.01% | 252 |
|
|
2014
Q3 | $53.8K | Hold |
4,559
| – | – | 0.01% | 265 |
|
|
2014
Q2 | $58.2K | Hold |
4,559
| – | – | 0.01% | 261 |
|
|
2014
Q1 | $61.6K | Hold |
4,559
| – | – | 0.01% | 259 |
|
|
2013
Q4 | $54.8K | Hold |
4,559
| – | – | 0.01% | 265 |
|
|
2013
Q3 | $53.5K | Hold |
4,559
| – | – | 0.01% | 275 |
|
|
2013
Q2 | $42.3K | Buy |
+4,559
| New | +$38.7K | ﹤0.01% | 298 |
|
Other funds holding BSX
BG
Estabrook Capital Management's BSX Position: Q4 2021 in Review
Estabrook Capital Management sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 3,359 shares — an estimated $146K sold.
Estabrook Capital Management first reported a position in BSX in Q2 2013 and held it in 34 quarters. The position peaked at $152K in Q4 2019. 889 funds tracked by Wall St. Rank hold BSX as of Q4 2021.
- Estabrook Capital Management reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
- Estabrook Capital Management sold 3,359 Boston Scientific shares in Q4 2021, an estimated $146K.
- Estabrook Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 34 quarters.
- Estabrook Capital Management's Boston Scientific position peaked at $152K in Q4 2019.
- 889 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.
Based on Estabrook Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.